We are live on ! Find out more
GFA

Godfrey Financial Associates Portfolio holdings

AUM $131M
This Fund
S&P 500
This Quarter Est. Return
+14.83%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$131M
AUM Growth
+$14.1M
Cap. Flow
+$46.6K
Cap. Flow %
0.04%
Top 10 Hldgs %
49.4%
Holding
1,138
New
28
Increased
129
Reduced
145
Closed
48
Avg Time Held
1.9 quarters
Top 10 Avg Time Held
1.9 quarters
Top 20 Avg Time Held
1.8 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 77.26%
2 Technology 8.99%
3 Financials 3.44%
4 Communication Services 2.12%
5 Healthcare 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PRIM icon
926
Primoris Services
PRIM
$4.34B
$396 ﹤0.01%
4
-1
-20% -$131
2025 Q4
2 quarters
MP icon
927
MP Materials
MP
$8.34B
$392 ﹤0.01%
7
– –
2025 Q4
2 quarters
HALO icon
928
Halozyme
HALO
$12.3B
$391 ﹤0.01%
5
-2
-29% -$136
2025 Q4
2 quarters
IONQ icon
929
IonQ
IONQ
$17.4B
$373 ﹤0.01%
7
– –
2025 Q4
2 quarters
CC icon
930
Chemours
CC
$2.09B
$369 ﹤0.01%
18
– –
2025 Q4
2 quarters
CENX icon
931
Century Aluminum
CENX
$3.66B
$368 ﹤0.01%
8
– –
2025 Q4
2 quarters
SCHL icon
932
Scholastic
SCHL
$689M
$368 ﹤0.01%
8
– –
2025 Q4
2 quarters
SPTM icon
933
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.2B
$363 ﹤0.01%
4
– –
2026 Q1
1 quarter
IART icon
934
Integra LifeSciences
IART
$1.03B
$359 ﹤0.01%
20
– –
2025 Q4
2 quarters
NXST icon
935
Nexstar Media Group
NXST
$4.83B
$357 ﹤0.01%
2
– –
2026 Q1
1 quarter
SGRY icon
936
Surgery Partners
SGRY
$1.75B
$353 ﹤0.01%
21
– –
2025 Q4
2 quarters
PCVX icon
937
Vaxcyte
PCVX
$11B
$349 ﹤0.01%
6
– –
2025 Q4
2 quarters
EQNR icon
938
Equinor
EQNR
$100B
$345 ﹤0.01%
11
– –
2025 Q4
2 quarters
PANW icon
939
Palo Alto Networks
PANW
$333B
$341 ﹤0.01%
1
– –
2025 Q4
2 quarters
ROP icon
940
Roper Technologies
ROP
$35.9B
$338 ﹤0.01%
1
– –
2025 Q4
2 quarters
NE icon
941
Noble Corp
NE
$6.79B
$336 ﹤0.01%
9
– –
2025 Q4
2 quarters
PRVA icon
942
Privia Health
PRVA
$2.61B
$334 ﹤0.01%
13
– –
2026 Q1
1 quarter
QDEL icon
943
QuidelOrtho
QDEL
$833M
$333 ﹤0.01%
19
– –
2025 Q4
2 quarters
RYTM icon
944
Rhythm Pharmaceuticals
RYTM
$6.37B
$333 ﹤0.01%
3
– –
2026 Q1
1 quarter
GSAT icon
945
Globalstar
GSAT
$10.8B
$325 ﹤0.01%
4
-2
-33% -$161
2025 Q4
2 quarters
OC icon
946
Owens Corning
OC
$9.29B
$318 ﹤0.01%
2
– –
2025 Q4
2 quarters
BHF icon
947
Brighthouse Financial
BHF
$2.87B
$317 ﹤0.01%
5
-1
-17% -$62
2025 Q4
2 quarters
CNK icon
948
Cinemark Holdings
CNK
$4.17B
$317 ﹤0.01%
10
– –
2025 Q4
2 quarters
OSCR icon
949
Oscar Health
OSCR
$10B
$314 ﹤0.01%
11
-3
-21% -$65
2025 Q4
2 quarters
QBTS icon
950
D-Wave Quantum Inc
QBTS
$5.94B
$312 ﹤0.01%
13
– –
2025 Q4
2 quarters

Similar funds

Godfrey Financial Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Godfrey Financial Associates held 1,138 positions worth $131M, up 12% from $117M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Godfrey Financial Associates's Q2 2026 filing shows 28 new, 129 increased, 145 reduced and 48 closed positions. Its largest new stake was iShares ESG Advanced MSCI USA ETF: 4,134 shares worth $287K. The largest sale was iShares MSCI EAFE Growth ETF, an estimated $492K.

By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 77% a quarter earlier, followed by Technology and Financials.

  • Godfrey Financial Associates's largest Q2 2026 buy was iShares ESG Advanced MSCI USA ETF: 4,134 shares worth $287K.
  • Godfrey Financial Associates added most to iShares International Select Dividend ETF in Q2 2026, an estimated $187K increase.
  • Godfrey Financial Associates's biggest Q2 2026 reduction was iShares MSCI EAFE Growth ETF, cutting an estimated $492K.
  • Godfrey Financial Associates fully exited Targa Resources in Q2 2026, selling an estimated $50.1K.
  • Godfrey Financial Associates's ten largest holdings make up 49% of its $131M portfolio in Q2 2026.
  • Godfrey Financial Associates opened 28 new positions and closed 48 in Q2 2026.
  • Godfrey Financial Associates's portfolio value rose 12% quarter-over-quarter to $131M.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.